Products

Survodutide

xrd@hkxingruida.com

Product Description

Survodutide is a dual agonist that activates both the glucagon receptor and the GLP-1 receptor. It has potential for treating metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, and is also being studied for the treatment of overweight and obesity.

Specifically, the functions of survodutide can be summarized as follows:

Improving liver fibrosis:

The glucagon receptor agonist component in survodutide increases energy expenditure and directly affects the liver, helping to improve liver fibrosis.

Reducing appetite and increasing satiety:

The GLP-1 receptor agonist component effectively reduces appetite and increases satiety, thereby aiding weight management.

Treatment of MASH:

Survodutide has demonstrated significant efficacy in the treatment of MASH and has been granted Fast Track designation by the US FDA.

Treatment of overweight and obesity:

Survodutide has also demonstrated positive efficacy in treating overweight or obese patients, with some patients experiencing significant weight loss following treatment.

Certificate

“Strength builds the foundation, and excellent services reach all over the world.”

create win-win situation with customers

We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.

    RELATED PRODUCTS